Obianda, Genrose .

HRN: 22-84-19  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/11/2023
METRONIDAZOLE 500MG (TAB)
05/11/2023
05/17/2023
ORAL
500 Mg
BID
S/P NSVD With RMLE And Repair Thickly Meconium Stained
Waiting Final Action 

Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: Guideline Not Available

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: